Health authorities are warning consumers about the “pot fever” that has gripped the US as companies seek to grow their own supply of pot.
US President Donald Trump is expected to sign an executive order on Wednesday that could pave the way for the cultivation and sale of cannabis in the US.
It will be the first federal cannabis law since 1937, when the Controlled Substances Act was signed into law.
Marijuana has been illegal since it was federally classified as a Schedule I drug, meaning it has no medical value.
The US has a relatively small cannabis population, which makes it difficult to measure.
But the Drug Enforcement Agency (DEA) has been issuing warnings for months about the rise in pot-related incidents.
The DEA estimates that at least one person is dying every week from cannabis related incidents, and that there are more than 8,500 people under arrest for marijuana-related offenses in the United States.
Many of those cases are linked to people who are over 21, or are caught with less than one ounce of pot, according to a DEA press release.
“It is imperative that people understand that the potential risks associated with cannabis use are real and that the use of cannabis is associated with a substantial risk of injury, including death,” the DEA said in the statement.
The Trump administration also announced in February that it would allow some states to legalize recreational use of marijuana, but not medical cannabis.
US state governments and the DEA are also set to vote in November on a bill that would allow recreational use and sales of marijuana.
But in recent months, the DEA has warned that the law could put a damper on cannabis-related activity.
In April, the agency said that more than 3,600 people were arrested each week on marijuana-based charges.
That figure could increase further if recreational sales of the drug are allowed to go forward.
The drug has become a hot topic of debate as states begin to approve recreational cannabis, which would open up an entire new industry for the US economy.
The cannabis industry has been booming since 2016, when Colorado, Washington and Alaska legalized recreational marijuana.
It was then that medical marijuana companies were able to open their doors to the general public, and there has been a boom in sales since.
In 2016, US medical marijuana sales reached $2.4 billion.
Now, the industry is forecast to reach $12.7 billion in 2019, according an October survey from CB Insights.
“The cannabis industry is at the point now where it can be a catalyst for economic growth and jobs growth in the next five years,” said Robert Langer, a cannabis industry analyst at CB Insight.
However, the growing popularity of recreational marijuana could pose risks to some companies.
“If you’re a medical marijuana patient in Colorado or Washington, you’re going to be dealing with a higher THC (tetrahydrocannabinol, the active ingredient in marijuana) dose, but the average dose for the average person in Colorado is 30 milligrams of THC,” Langer said.
“There’s a risk that that could increase the risk of overdose and death.”